Literature DB >> 2741993

Discontinuation of dialysis therapy as a cause of death.

F K Port1, R A Wolfe, V M Hawthorne, C W Ferguson.   

Abstract

Discontinuation of life-sustaining dialysis therapy led to death in 282 of 5,208 patients who started therapy for end-stage renal disease (ESRD) in Michigan during 1980-1985 with a follow-up through 1986. Based on life table estimates at 60 months after initiation of therapy, 9.4% of patients overall died due to termination of dialysis, 11% of females versus 8% of males (p = 0.02), 0.1-3.4% for ages less than or equal to 49 years versus 56% for greater than 80 years, 12% for white versus 4% for black patients (p less than 0.001) and 16% for diabetic ESRD patients (higher than any other group, p less than 0.05). The Cox regression model confirms these significant findings for race, diabetes and age, and reveals a significant 60% increase in overall withdrawals for the years 1980-1985 (1.10/year, p less than 0.02). A separate analysis of discontinuation of dialysis as the percentage of all 2,564 dialysis deaths in prevalence cases for 1980-1984 revealed an overall ratio of 8.9% with a significant difference for ages less than or equal to 64 versus greater than or equal to 65 (p less than 0.001), race (p less than 0.001) but not for prior transplant failure or continuous ambulatory peritoneal dialysis therapy. Whereas the results for age and diabetes were expected, the significant increase of dialysis withdrawal over time and the racial difference are unexplained by information available at the Michigan Kidney Registry and indicate the need for exploration by further studies.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1989        PMID: 2741993     DOI: 10.1159/000167954

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

1.  Preferences for dialysis withdrawal and engagement in advance care planning within a diverse sample of dialysis patients.

Authors:  Manjula Kurella Tamura; Mary K Goldstein; Eliseo J Pérez-Stable
Journal:  Nephrol Dial Transplant       Date:  2009-09-03       Impact factor: 5.992

2.  Assessment of quality of life in end-stage renal disease.

Authors:  O L Deniston; P Carpentier-Alting; J Kneisley; V M Hawthorne; F K Port
Journal:  Health Serv Res       Date:  1989-10       Impact factor: 3.402

Review 3.  Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature.

Authors:  Carlos G Musso; Konstantina Trigka; Periklis Dousdampanis; Jose Jauregui
Journal:  Int Urol Nephrol       Date:  2014-12-05       Impact factor: 2.370

4.  Geographic variation in black-white differences in end-of-life care for patients with ESRD.

Authors:  Bernadette A Thomas; Rudolph A Rodriguez; Edward J Boyko; Cassianne Robinson-Cohen; Annette L Fitzpatrick; Ann M O'Hare
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-11       Impact factor: 8.237

5.  Racial/Ethnic Differences in Dialysis Discontinuation and Survival after Hospitalization for Serious Conditions among Patients on Maintenance Dialysis.

Authors:  Abdulkareem Agunbiade; Abhijit Dasgupta; Michael M Ward
Journal:  J Am Soc Nephrol       Date:  2019-12-13       Impact factor: 10.121

6.  The effect of values and culture on life-support decisions.

Authors:  J Klessig
Journal:  West J Med       Date:  1992-09

7.  Association of Race and Poverty With Mortality Among Nursing Home Residents on Maintenance Dialysis.

Authors:  Robert Nee; John S Thurlow; Keith C Norris; Christina Yuan; Maura A Watson; Lawrence Y Agodoa; Kevin C Abbott
Journal:  J Am Med Dir Assoc       Date:  2019-03-28       Impact factor: 7.802

8.  Regional variation in care at the end of life: discontinuation of dialysis.

Authors:  Charles E Gessert; Irina V Haller; Brian P Johnson
Journal:  BMC Geriatr       Date:  2013-05-01       Impact factor: 3.921

9.  Factors influencing dialysis withdrawal: a scoping review.

Authors:  Hammad Ali Qazi; Helen Chen; Meng Zhu
Journal:  BMC Nephrol       Date:  2018-04-24       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.